|
|
| SC6A1_RAT |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
2.938e-45 |
0.33
|
| NK2R_BOVIN |
TACR2 |
Substance-K receptor |
2.147e-35 |
0.37
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
1.604e-27 |
0.33
|
| ZN664_CAVPO |
ZNF664 |
Zinc finger protein 664 |
6.442e-26 |
0.32
|
| 5HT7R_MOUSE |
Htr7 |
5-hydroxytryptamine receptor 7 |
1.246e-25 |
0.32
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
1.167e-24 |
0.54
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
3.773e-21 |
0.54
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
3.8e-21 |
0.40
|
| NK2R_RAT |
Tacr2 |
Substance-K receptor |
3.924e-21 |
0.37
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
5.995e-21 |
0.37
|
| US28_HCMVA |
US28 |
G-protein coupled receptor homolog US28 |
1.077e-20 |
0.29
|
| SC6A1_HUMAN |
SLC6A1 |
Sodium- and chloride-dependent GABA transporter 1 |
1.505e-20 |
0.31
|
| H10_HUMAN |
H1-0 |
Histone H1.0 |
1.11e-16 |
0.32
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
1.11e-16 |
0.40
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
3.331e-16 |
0.45
|
| VMAT2_HUMAN |
SLC18A2 |
Synaptic vesicular amine transporter |
1.832e-14 |
0.28
|
| CASB_RAT |
Csn2 |
Beta-casein |
1.987e-14 |
0.32
|
| 5HT2A_PIG |
HTR2A |
5-hydroxytryptamine receptor 2A |
2.958e-13 |
0.38
|
| DRD1_PIG |
DRD1 |
D(1A) dopamine receptor |
7.278e-13 |
0.38
|
| OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
1.356e-12 |
0.45
|
| CALM_BOVIN |
CALM |
Calmodulin |
7.204e-12 |
0.32
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
9.698e-12 |
0.37
|
| VMAT2_MOUSE |
Slc18a2 |
Synaptic vesicular amine transporter |
1.383e-11 |
0.28
|
| Q8HY88_BOVIN |
KCNK2 |
Potassium channel subfamily K member 2 |
1.482e-11 |
0.28
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
9.434e-11 |
0.45
|
| KCNK2_HUMAN |
KCNK2 |
Potassium channel subfamily K member 2 |
3.683e-10 |
0.32
|
| DRD5_RAT |
Drd5 |
D(1B) dopamine receptor |
9.852e-10 |
0.28
|
| SC6A1_MOUSE |
Slc6a1 |
Sodium- and chloride-dependent GABA transporter 1 |
1.056e-09 |
0.33
|
| AP2S1_RAT |
Ap2s1 |
AP-2 complex subunit sigma |
1.574e-09 |
0.32
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
2.245e-09 |
0.38
|
| DRD3_CHLAE |
DRD3 |
D(3) dopamine receptor |
5.398e-09 |
0.32
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
6.697e-09 |
0.47
|
| ERG2_YEAST |
ERG2 |
C-8 sterol isomerase |
1.022e-08 |
0.35
|
| NK3R_CAVPO |
TACR3 |
Neuromedin-K receptor |
1.14e-08 |
0.32
|
| DRD1_RAT |
Drd1 |
D(1A) dopamine receptor |
1.502e-08 |
0.47
|
| VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
4.245e-08 |
0.30
|
| ADA1A_HUMAN |
ADRA1A |
Alpha-1A adrenergic receptor |
6.01e-08 |
0.34
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
1.019e-07 |
0.36
|
| 5HT5A_MOUSE |
Htr5a |
5-hydroxytryptamine receptor 5A |
1.315e-07 |
0.30
|
| EBP_HUMAN |
EBP |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase |
1.802e-07 |
0.35
|
| ADA2B_HUMAN |
ADRA2B |
Alpha-2B adrenergic receptor |
2.263e-07 |
0.32
|
| 5HT7R_RAT |
Htr7 |
5-hydroxytryptamine receptor 7 |
2.663e-07 |
0.32
|
| GASR_RAT |
Cckbr |
Gastrin/cholecystokinin type B receptor |
4.802e-07 |
0.31
|
| TYTR_TRYBB |
TPR |
Trypanothione reductase |
4.848e-07 |
0.32
|
| ADA2C_HUMAN |
ADRA2C |
Alpha-2C adrenergic receptor |
6.157e-07 |
0.34
|
| CCKAR_CAVPO |
CCKAR |
Cholecystokinin receptor type A |
1.103e-06 |
0.33
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
2.144e-06 |
0.38
|
| ADA1B_HUMAN |
ADRA1B |
Alpha-1B adrenergic receptor |
2.784e-06 |
0.32
|
| ADA1B_RAT |
Adra1b |
Alpha-1B adrenergic receptor |
3.014e-06 |
0.32
|
| ADA1D_HUMAN |
ADRA1D |
Alpha-1D adrenergic receptor |
3.066e-06 |
0.32
|
| ADA2A_HUMAN |
ADRA2A |
Alpha-2A adrenergic receptor |
3.157e-06 |
0.34
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
5.909e-06 |
0.33
|
| DRD2_CHLAE |
DRD2 |
D(2) dopamine receptor |
8.646e-06 |
0.32
|
| NK2R_MOUSE |
Tacr2 |
Substance-K receptor |
8.684e-06 |
0.28
|